As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...
Glaucoma Awareness Month 2026 highlights how a family history of kala motia can raise your risk of vision loss up to 10 times ...
Please provide your email address to receive an email when new articles are posted on . Patients who underwent cataract surgery and received blue-light filtering IOLs had fewer glaucoma diagnoses. No ...
Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ...
OT dives into a key topic in the education programme at 100% Optical 2026. This week: Sana Hamid shares insight into her ...
Glaucoma may be more likely to develop in glaucoma suspects with a history of anxiety or both anxiety and depression, according to a retrospective cohort study in British Journal of Ophthalmology.
Organically Human on MSN
Study Finds Association Between Statins and Glaucoma
Glaucoma is a leading cause of blindness, affecting millions worldwide. It develops when increased intraocular pressure (IOP) ...
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma treatment VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis ...
President and CEO, Thomas M. Brunner announced the 2026 Gala honorees today including philanthropists Nancy and Patrick Forster, visionary ophthalmologist, researcher, and entrepreneur Barbara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback